1. Home
  2. GCTS vs LONA Comparison

GCTS vs LONA Comparison

Compare GCTS & LONA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GCT Semiconductor Holding Inc.

GCTS

GCT Semiconductor Holding Inc.

HOLD

Current Price

$3.38

Market Cap

93.5M

Sector

Finance

ML Signal

HOLD

LONA

LeonaBio Inc. Common Stock

N/A

Current Price

$10.51

Market Cap

90.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GCTS
LONA
Founded
1998
2011
Country
United States
United States
Employees
126
19
Industry
Blank Checks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
93.5M
90.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GCTS
LONA
Price
$3.38
$10.51
Analyst Decision
Strong Buy
Buy
Analyst Count
2
1
Target Price
$3.50
$10.00
AVG Volume (30 Days)
7.5M
32.5K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1,052.30
N/A
Revenue Next Year
$140.29
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.90
$4.21
52 Week High
$3.57
$14.21

Technical Indicators

Market Signals
Indicator
GCTS
LONA
Relative Strength Index (RSI) 81.08 57.58
Support Level $1.24 $7.88
Resistance Level N/A $11.96
Average True Range (ATR) 0.40 1.03
MACD 0.19 -0.00
Stochastic Oscillator 89.78 67.76

Price Performance

Historical Comparison
GCTS
LONA

About GCTS GCT Semiconductor Holding Inc.

GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness. Geographically, operates in South Korea and the United States, with maximum revenue from the USA.

About LONA LeonaBio Inc. Common Stock

LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

Share on Social Networks: